Positron Emission Tomography Scanners Market: Global Industry Analysis and Forecast (2025-2032)

The Positron Emission Tomography Scanners Market size was valued at USD 650.12 Million in 2024 and the total Positron Emission Tomography Scanners revenue is expected to grow at a CAGR of 5.9% from 2025 to 2032, reaching nearly USD 1028.40 Million.
Positron Emission Tomography Scanners Market Overview:
A positron emission tomography (PET) scan is a type of imaging examination that can provide information about how your tissues and organs are working. To reveal this activity, a PET scan employs a radioactive substance (tracer). This scan can occasionally detect disease before other imaging tests reveal it. To know about the Research Methodology :- Request Free Sample Report
Positron Emission Tomography [PET] Scanners Market Dynamics:
Rising prevalence of cancer and other chronic diseases globally are the major factors driving the market growth.

The rising need for PET analysis in radiopharmaceuticals is one of the factors driving the market's growth. The World Nuclear Organization states that around 20 million nuclear medicine treatments are performed annually among 311 million Americans, around 10 million among 500 million Europeans, and around 560,000 among 21 million Australians. Over the forecast period, rising cancer prevalence is likely to drive growth in the global positron emission tomography (PET) scanner market. According to the American Cancer Society, there will be 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States year 2021.

To provide more trustworthy data on the metabolic and functional environment, PET technology has been integrated with CT and MRI. PET is widely used in oncology to diagnose many types of cancer, as well as in the diagnosis of neurological problems and cardiovascular problems. In 2018, the EXPLORER human scanner (a total-body PET/CT scanner) was introduced, demonstrating its potential to provide high-quality images in less time while using significantly less radiotracer (18F-FDG). Furthermore, the availability of Medicare coverage for PET scanning is projected to boost market growth. PET/computed tomography (PET-CT) scanners that use the radioisotope 18F-fluorodeoxyglucose (FDG) for cancer diagnosis has a high success rate. The growing geriatric population in both developed and developing nations will have a substantial beneficial impact on the growth of the PET scanner market. Aging causes physiological changes that render people more vulnerable to chronic diseases including diabetes, heart disease, and stroke.

Continuous reimbursement cuts are projected to stifle market growth. Furthermore, the market's growth is projected to be limited by radiopharmaceutical’s short half-life. The most often used radiotracer in PET imaging is fluoro-deoxy glucose (FDG), which uses fluorine-18 as a tracer. The half-life of the radiotracer is just under two hours. As a result, its diagnostic utility is limited. These factors may impact negatively on the market growth.

The report has profiled twenty three key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Positron Emission Tomography [PET] Scanners Market Segment Analysis:
By End User, the Hospitals segment holds the largest market share in the Global Positron Emission Tomography Scanners Market. According to MMR analysis, the segment is further expected to grow at a CAGR of 5.10% during the forecast period. This leadership stems from their robust medical infrastructure, which enables seamless integration of advanced diagnostic technologies like PET imaging. These institutions serve as primary hubs for diagnosing and managing complex conditions across oncology, cardiology, and neurology fields where PET scanners play a critical role in detecting metabolic activity, staging cancer, evaluating cardiac function, and identifying neurological disorders. The high patient inflow in hospitals further amplifies the demand for reliable and rapid diagnostic tools, making PET scanners essential equipment.

Additionally, hospitals are often involved in clinical research and drug development trials, driving the need for precision imaging technologies to support evidence-based decisions. Their ability to invest in cutting-edge equipment and skilled personnel enhances the accuracy and efficiency of diagnoses. The strong presence of PET scanners in hospitals not only accelerates early disease detection but also supports personalized treatment planning and monitoring. This sustained reliance on PET technology within hospital settings significantly contributes to the market's growth, reinforcing the segment's pivotal role and shaping innovation trends across the broader medical imaging landscape.
Positron Emission Tomography [PET] Scanners Market Regional Insights:
North America is expected to dominate the global market during forecast period.

Because of the strong need for precise diagnostics and technological advancements in PET technology in the region, North America dominates the positron emission tomography market. The United States now dominates the North American positron emission tomography market, and this is expected to continue for the forecast period. Higher market share is attributable to increased awareness of the benefits of modern imaging technology such as positron emission tomography and the benefits of correct diagnosis. Disease burden is increasing, and demographic trends such as population ageing are favourable for market growth.

The report also helps in understanding Global Positron Emission Tomography Scanners Market dynamics, structure by analyzing the market segments and project the Global Positron Emission Tomography [PET] Scanners Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Positron Emission Tomography Scanners Market make the report investor’s guide.

Positron Emission Tomography Scanners Market, Key Developments:

1. Cerveau Technologies Inc., a diagnostic technology researcher and producer, teamed with Alector, LLC in March 2021 to market its investigational imaging agent (MK-6240) for use in PET scans to monitor the status and evolution of neurofibrillary tangles in the brain.

2. Siemens Healthineers unveiled a new Biograph Vision positron emission tomography/computed tomography (PET/CT) system in February 2021, which was installed at the Hospital of the University Of Pennsylvania (HUP) in Philadelphia, making it the first health care institution in the United States to do so.
Global Positron Emission Tomography [PET] Scanners Market Scope: Inquire before buying



Global Positron Emission Tomography Scanners Market


Report Coverage
Details


Base Year:
2024
Forecast Period:
2025-2032


Historical Data:
2019 to 2025
Market Size in 2024:
US $ 650.12 Mn.


Forecast Period 2025 to 2032 CAGR:
5.9%
Market Size in 2032:
US $ 1028.40 Mn.


 Segments Covered:
by Product Type
Full Ring PET Scanners
Partial Ring PET Scanners


by Application
Cardiology
Neurology
Oncology


by End User
Hospitals
Diagnostic Imaging Centers



North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Positron Emission Tomography Scanners Market Key Players are:
1. GE Healthcare.
2. Siemens Healthineers
3. Koninklijke Philips N.V.
4. Canon Medical Systems Corporation
5. Hitachi Medical Corporation
6. Shimadzu Corporation
7. Neusoft Medical Systems Co., Ltd.
8. United Imaging Healthcare Co., Ltd.
9. Shenzhen Anke High-Tech Co., Ltd.
10. Yangzhou Kindsway Biotech Co., Ltd.
11. Mediso Ltd.
12. Positron Corporation
13. PerkinElmer Inc.
14. Bruker Corporation
15. Radiology Oncology Systems Inc.
16. NeuroLogica Corporation
17. Carestream Health
Frequently Asked questions
1. What is the market size of the Global Positron Emission Tomography Scanners Market in 2024?
Ans. The market size Global Positron Emission Tomography Scanners Market in 2024 was USD 650.12 Million.

2. What are the different segments of the Global Positron Emission Tomography [PET] Scanners Market ?
Ans. The Global Positron Emission Tomography [PET] Scanners Market is divided into Product Type, Application and End User.

3. What is the study period of this market?
Ans. The Global Positron Emission Tomography [PET] Scanners Market will be studied from 2024 to 2032.

4. Which region is expected to hold the highest Global Positron Emission Tomography [PET] Scanners Market share?
Ans. The Asia Pacific dominates the market share in the market.

5. What is the Forecast Period of Global Positron Emission Tomography Scanners Market ?
Ans. The Forecast Period of the market is 2025-2032 in the market.